Apoptosis: potential for disease therapies. by Revillard, J, Adorini, L, Goldman, M, Kabelitz, D, Waldmann, H

T cell sensitivity to HLA class I-mediated apoptosis is dependent on interleukin-2 and interleukin-4. by Genestier, L, Paillot, R, Bonnefoy-Berard, N, Waldmann, H, Revillard, J

A noncomitogenic CD2R monoclonal antibody induces apoptosis of activated T cells by a CD95/CD95-L-dependent pathway. by Fournel, S, Robinet, E, Bonnefoy-Bérard, N, Assossou, O, Flacher, M, Waldmann, H, Bismuth, G, Revillard, J

CD4 mAbs prevent progression of alloactivated CD4+ T cells into the S phase of the cell cycle without interfering with early activation signals. by Fournel, S, Vincent, C, Assossou, O, Gorman, S, Robinet, E, Phillips, J, Flacher, M, Cordier, G, Waldmann, H, Revillard, J

Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain. by Genestier, L, Paillot, R, Bonnefoy-Berard, N, Meffre, G, Flacher, M, Fèvre, D, Liu, Y, Le Bouteiller, P, Waldmann, H, Engelhard, V, Banchereau, J, Revillard, J

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study by ten Kate, M, Redolfi, A, Peira, E, Bos, I, Vos, S, Vandenberghe, R, Gabel, S, Schaeverbeke, J, Scheltens, P, Blin, O, Richardson, J, Bordet, B, Wallin, A, Eckerstrom, C, Molinuevo, J, Engelborghs, S, Van Broeckhoven, C, Martinez-Lage, P, Popp, J, Tsolaki, M, Verhey, F, Tsolaki, M, Baird, A, Legido-Quigley, C, Bertram, L, Dobricic, V, Zetterberg, H, Lovestone, S, Streffer, J, Bianchetti, S, Novak, G, Revillard, J, Gordon, M, Xie, Z, Wottschel, V, Frisoni, G, Visser, P, Barkhof, F